XML 25 R16.htm IDEA: XBRL DOCUMENT v3.7.0.1
C. STOCKHOLDERS EQUITY (Tables)
6 Months Ended
Mar. 31, 2017
C. Stockholders Equity Tables  
Stock options, stock bonuses and compensation granted by the Company

Stock options, stock bonuses and compensation granted by the Company as of March 31, 2017 are as follows:

 

Name of Plan  Total Shares Reserved Under Plans  Shares Reserved for Outstanding Options  Shares Issued  Remaining Options/Shares Under Plans
             
Incentive Stock Options Plans   3,460,000    1,648,966    N/A    1,511,334 
Non-Qualified Stock Option Plans   9,680,000    6,531,752    N/A    2,420,630 
Stock Bonus Plans   5,594,000    N/A    4,448,479    1,144,694 
Stock Compensation Plan   3,350,000    N/A    2,189,749    1,127,200 
Incentive Stock Bonus Plan   16,000,000    N/A    15,600,000    400,000 

 

Stock options, stock bonuses and compensation granted by the Company as of September 30, 2016 are as follows:

 

Name of Plan  Total Shares Reserved Under Plans  Shares Reserved for Outstanding Options  Shares Issued  Remaining Options/Shares Under Plans
             
Incentive Stock Option Plans   3,460,000    1,648,966    N/A    1,511,334 
Non-Qualified Stock Option Plans   9,680,000    6,940,321    N/A    2,059,261 
Bonus Plans   5,594,000    N/A    3,161,211    2,431,962 
Stock Compensation Plan   3,350,000    N/A    1,985,037    1,331,912 
Incentive Stock Bonus Plan   16,000,000    N/A    15,600,000    400,000 

 

Stock option activity:

 

   Six Months Ended March 31,
   2017  2016
 Granted    —      210,000 
 Expired    382,037    —   
 Forfeited    26,532    50,998 

 

   Three Months Ended March 31,
   2017  2016
 Granted    —      60,000 
 Expired    5,000    —   
 Forfeited    26,532    28,032 

 

Schedule of employees and non-employees stock compensation

Stock-Based Compensation Expense

 

   Six Months Ended March 31,
   2017  2016
  Employees   $677,755   $845,100 
  Non-employees   $112,778   $472,061 

 

   Three Months Ended March 31,
   2017  2016
  Employees   $365,380   $417,190 
  Non-employees   $34,225   $142,866 

 

Derivative Liabilities, Warrants and Other Options

The following chart presents the outstanding warrants and non-employee options, listed by expiration date at March 31, 2017:

 

Warrant  Issue Date  Shares Issuable upon Exercise of Warrant  Exercise Price  Expiration Date  Reference
                
Series DD  12/8/16   34,024,000   $0.18   6/8/17   1 
Series N  8/18/08   2,844,627   $0.53   8/18/17     
Series EE  12/8/16   34,024,000   $0.18   9/8/17   1 
Series U  4/17/14   445,514   $1.75   10/17/17   1 
Series S  10/11/13- 10/24/14   25,928,010   $ 1.25   10/11/18   1 
Series V  5/28/15   20,253,164   $0.79   5/28/20   1 
Series W  10/28/15   17,223,248   $0.67   10/28/20   1 
Series X  1/13/16   3,000,000   $0.37   1/13/21     
Series Y  2/15/16   650,000   $0.48   2/15/21     
Series ZZ  5/23/16   500,000   $0.55   5/18/21   1 
Series BB  8/26/16   400,000   $0.55   8/22/21   1 
Series Z  5/23/16   6,600,000   $0.55   11/23/21   1 
Series FF  12/8/16   1,701,200   $0.16   12/1/21   1 
Series CC  12/8/16   17,012,000   $0.20   12/8/21   1 
Series HH  2/23/17   500,000   $0.13   2/16/22   1 
Series AA  8/26/16   5,000,000   $0.55   2/22/22   1 
Series JJ  3/14/17   750,000   $0.13   3/8/22   1 
Series GG  2/23/17   10,000,000   $0.12   8/23/22   1 
Series II  3/14/17   15,000,000   $0.12   9/14/22   1 
Consultants  12/28/12- 7/1/16   570,000   0.37- $2.80   4/24/17- 6/30/19   2 

 

Tabular disclosure of derivative liabilities at fair value

The table below presents the warrant liabilities and their respective balances at the balance sheet dates:

 

   March 31,
2017
  September 30,
2016
Series S warrants  $531,525   $3,111,361 
Series U warrants   —      —   
Series V warrants   202,532    1,620,253 
Series W warrants   190,443    1,799,858 
Series Z warrants   142,341    970,604 
Series ZZ warrants   9,414    70,609 
Series AA warrants   116,996    763,661 
Series BB warrants   8,250    58,588 
Series CC warrants   630,554    —   
Series DD warrants   29,324    —   
Series EE warrants   179,169    —   
Series FF warrants   73,816    —   
Series GG warrants   506,426    —   
Series HH warrants   24,290    —   
Series II warrants   755,040    —   
Series JJ warrants   36,625    —   
           
Total warrant liabilities  $3,436,745   $8,394,934 

 

Schedule Of Gains and (Losses) on Derivative Liabilities

The table below presents the gains on the warrant liabilities for the six months ended March 31:

 

   2017  2016
Series S warrants  $2,579,836   $3,147,660 
Series U warrants   —      26,731 
Series V warrants   1,417,721    1,822,785 
Series W warrants   1,609,415    532,054 
Series Z warrants   828,263    —   
Series ZZ warrants   61,195    —   
Series AA warrants   646,665    —   
Series BB warrants   50,338    —   
Series CC warrants   429,869    —   
Series DD warrants   413,948    —   
Series EE warrants   512,238    —   
Series FF warrants   47,166    —   
Series GG warrants   108,211    —   
Series HH warrants   5,340    —   
Series II warrants   161,419    —   
Series JJ warrants   7,988    —   
           
Net gain on warrant liabilities  $8,879,612   $5,529,230 

 

The table below presents the gains and (losses) on the warrant liabilities for the three months ended March 31:

 

   2017  2016
Series S warrants  $(41,485)  $321,507 
Series U warrants   —      (4,455)
Series V warrants   —      (1,417,721)
Series W warrants   (58,189)   (1,493,061)
Series Z warrants   (40,524)   —   
Series ZZ warrants   (2,689)   —   
Series AA warrants   (32,904)   —   
Series BB warrants   (2,334)   —   
Series CC warrants   (174,623)   —   
Series DD warrants   43,029    —   
Series EE warrants   (2,365)   —   
Series FF warrants   (19,574)   —   
Series GG warrants   108,211    —   
Series HH warrants   5,340    —   
Series II warrants   161,419    —   
Series JJ warrants   7,988    —   
           
Net loss on warrant liabilities  $(48,700)  $(2,593,730)